New synthesis platform allows for rapid cancer drug synthesis and testing
Imperial researchers have developed a new platform for the synthesis, analysis and testing of new compounds which may one day treat cancer
Feature
Eight things we learned about commercialising medical research at AYCI 2024
We learnt why you should channel Mary Somerville, how timing can make or break a startup, and other lessons from experts at All You Can Innovate 2024.
Impact of artificial intelligence on AMR: Common themes and challenges
Researchers gather to explore visions, themes & challenges around the use of Artificial Intelligence (AI) to tackle antimicrobial resistance (AMR).
New class of cancer and immunology drug targets mapped with new tagging system
Researchers have used ‘click chemistry’ to map the role of a group of enzymes that could be key for developing new medicines in cancer and immunology.
Unraveling the Secrets of Zombie cells
A new druggable pathway identified as a target for drugs against cancer and age-related diseases
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
New £28m Centre to forge the next generation of AI digital healthcare innovators
A new £28 million UKRI AI Centre for Doctoral Training at Imperial College London will train over 120 researchers to develop patient-ready technology.
1
Towards using quantum computing to speed up drug development
Researchers have developed a quantum processor that can perform crucial drug design methods, which could lead to more efficient drug development.
New mechanism found that maintains water balance within cells
Scientists have discovered a new mechanism that allows cells to maintain their ideal water availability from second to second.
Imperial President - College making big moves to accelerate medical innovation
Professor Hugh Brady says that Imperial is working to speed development of innovations that have potential to be as transformational as penicillin.
